drugset / Trial / NCT02307994

Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH

NCT02307994 ↗

Phase 4 Unknown 180 enrolled Livzon Pharmaceutical Group Inc.
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether uFSH is effective and safe in the treatment of male patients with severe oligospermia or azoospermia.

Timeline

Start
2014-08
Primary completion
2015-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject uFSH Unknown 75 iu —